161: Severe veno-occlusive disease after bone marrow transplantation in premature monozygotic twins with familial hemophagocytic lymphohistiocytosis (FLH) |
|
[18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making? |
|
Adrenocortical tumors and pheochromocytoma/paraganglioma initially mistaken as neuroblastoma — experiences from the GPOH-MET registry |
|
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study |
|
ATRT-02. Neuropsychological function in infant atypical teratoid/rhabdoid tumor versus low-grade glioma survivors reflects tumor malignancy and multimodal treatment [Abstract] |
|
ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance |
|
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with osteosarcoma and ependymoma |
|
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors |
|
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure |
|
A carboxy-terminal SMARCB1 point mutation induces hydrocephalus formation and affects AP-1 and neuronal signalling pathways in mice |
|
Changes in behavior and quality of life in German young children during the COVID-19 pandemic—results from the COVID kids bavaria study |
|
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification |
|
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors |
|
Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution |
|
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE host genome working group |
|
Development and preliminary validation of the sleep screening for children and adolescents with complex chronic conditions (SCAC) |
|
Dissecting the genomic complexity underlying medulloblastoma |
|
Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway |
|
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors |
|
Ethische Aspekte in der Aortenchirurgie: ein Fallbericht |
|
ETMR-05: Single-cell transcriptomics of ETMR reveals developmental cellular programs and tumor-pericyte communications in the microenvironment [Abstract] |
|
Genotype–phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry |
|
Global methylation profiling of lung cancer identifies novel methylated genes |
|
Health-related quality of life in children and adolescents with hereditary bleeding disorders and in children and adolescents with stroke: cross-sectional comparison to siblings and peers |
|
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup |
|
Identification and analyses of extra-cranial and cranial rhabdoid tumor molecular subgroups reveal tumors with cytotoxic T cell infiltration |
|
Improved 6-year overall survival in AT/RT - results of the registry study rhabdoid 2007 |
|
Influence of Turkish origin on hematology reference intervals in the German population |
|
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy |
|
Locally advanced adrenocortical carcinoma in children and adolescents — enigmatic and challenging cases |
|
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology |
|
Neurological manifestations in children and adolescents with neurofibromatosis type-1-implications for management and surveillance [Abstract] |
|
New brain tumor entities emerge from molecular classification of CNS-PNETs |
|
Next-generation personalised medicine for high-risk paediatric cancer patients – the INFORM pilot study |
|
Outcome for pediatric adreno-cortical tumors is best predicted by the COG stage and five-item microscopic score — report from the German MET studies |
|
Proton beam therapy for pediatric tumors of the central nervous system — experiences of clinical outcome and feasibility from the KiProReg Study |
|
Pseudohypoxic pheochromocytomas and paragangliomas dominate in children |
|
Refractory and relapsed paediatric ACC in the MET studies – a challenging situation necessitating novel diagnostic and therapeutic concepts |
|
A retrospective 5-year single center study highlighting the risk of cancer predisposition in adolescents and young adults |
|
Revisiting the genotype‐phenotype correlation in children with medullary thyroid carcinoma : a report from the GPOH‐MET registry |
|
Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors |
|
Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome |
|
A study of regulatory challenges of paediatric oncology phase I/II trial submissions and guidance on protocol development |
|
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor |
|